, 2013). Furthermore the viscoelastic properties of NFC resemble the physiological Epigenetic inhibitor mouse properties of extracellular matrices (Bhattacharya et al., 2012 and Miron-Mendoza et

al., 2010). The NFC aqueous suspensions behave as 1-compartmental hydrogels with pseudoplastic and thixotropic properties (Pääkkö et al., 2007). Pseudoplasticity induces a shear thinning effect which reduces viscosity with increased shear stress. Shear thinning therefore enables NFC hydrogels to be easily injected (Bhattacharya et al., 2012) as the extruding force of the syringe is enough to change NFC flow properties to lower the viscosity. While in static conditions, NFC retains higher viscosity due to the rearrangement of the fibers, which reverts the shear thinning effect. As an injectable hydrogel, NFC is able to deliver cells or therapeutic agents (e.g. proteins or peptides) into easily accessible target sites, such as under the skin. Additionally NFC hydrogels are biocompatible, non-toxic, and structurally

durable (Märtson et al., 1999 and Vartiainen et al., 2011). As a plant derived material, the NFC hydrogels are obtained from a non-animal and non-human source, being selleck screening library thus xeno-free. Additionally, cellulose based materials offer a broad modification capacity (Klemm et al., 2011), which is advantageous when designing new biomaterials. Currently, in biomedical and -pharmaceutical research, the hydrogels under investigation for the potential use of controlled release matrices can prove to be problematic in terms of gel activation properties (Hennink and van Nostrum, 2002), especially with injectable hydrogels. The need for an external source of activation presents additional complications and toxicity as crosslinking agents often used are potentially toxic compounds (Van Tomme et al., 2008), that need to be extracted from the gels before usage. This could prove to be difficult in the case of parenteral delivery,

such as subcutaneous injections. Furthermore, the crosslinkers may react with the imbedded drug compounds within the hydrogel, which MycoClean Mycoplasma Removal Kit may result to unwanted consequences or ineffective treatment. NFC overcomes this obstacle, as there is no need for activation methods such as the use of UV irradiation or chemical crosslinking due to the pseudoplasticity of the material. After administration (e.g. subcutaneous injection), NFC “gels” spontaneously, as the fibers rearrange to form a viscous gel; therefore avoiding all the complications with removing the crosslinking agents, potential toxicity or interactions between the crosslinking agents and the drug compounds in use. The aim of this study was to investigate the properties of plant-derived NFC hydrogel as an injectable platform or “implant” for drug release, in addition to examine the utility of SPECT/CT imaging to illustrate the behavior of hydrogels in vivo.